연구성과로 돌아가기
2023 연구성과별 연구자 정보 (1484 / 2675)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Korean Proficiency Tests for Pesticide Residues in Rice: Comparison of Various Proficiency Testing Evaluation Methods and Identification of Critical Factors for Multiresidue Analysis | Kim, Hyanghee | Kim, H | 4 | Natl Inst Agr Sci, 166 Nongsaengmyeong Ro, Wonju 55365, South Korea | hs8255@korea.kr;yamche79@korea.kr;shewaspretty@korea.kr;lhs8255@korea.kr; | |||||
| Korean Proficiency Tests for Pesticide Residues in Rice: Comparison of Various Proficiency Testing Evaluation Methods and Identification of Critical Factors for Multiresidue Analysis | Jeong, Wontae | Jeong, W | 5 | Natl Inst Agr Sci, 166 Nongsaengmyeong Ro, Wonju 55365, South Korea | hs8255@korea.kr;yamche79@korea.kr;shewaspretty@korea.kr;lhs8255@korea.kr; | |||||
| Korean Proficiency Tests for Pesticide Residues in Rice: Comparison of Various Proficiency Testing Evaluation Methods and Identification of Critical Factors for Multiresidue Analysis | Kim, Taekkyum | Kim, T | 6 | Natl Inst Agr Sci, 166 Nongsaengmyeong Ro, Wonju 55365, South Korea | hs8255@korea.kr;yamche79@korea.kr;shewaspretty@korea.kr;lhs8255@korea.kr; | |||||
| Korean Real-World Data on Patients With Unresectable Stage III NSCLC Treated With Durvalumab After Chemoradiotherapy: PACIFIC-KR | Park, Cheol-Kyu | Park, CK | 1 | Chonnam Natl Univ, Med Sch, Dept Internal Med, 322 Seoyang Ro, Hwasun 58128, Jeonnam, South Korea | AAT-9872-2021 | Park, Cheol-Kyu | 0000-0001-8701-0786 | Park, Cheol Kyu | droij@jnu.ac.kr; | |
| Korean Real-World Data on Patients With Unresectable Stage III NSCLC Treated With Durvalumab After Chemoradiotherapy: PACIFIC-KR | Park, Cheol-Kyu | Park, CK | 1 | Hwasun Hosp, 322 Seoyang Ro, Hwasun 58128, Jeonnam, South Korea | AAT-9872-2021 | Park, Cheol-Kyu | 0000-0001-8701-0786 | Park, Cheol Kyu | droij@jnu.ac.kr; | |
| Korean Real-World Data on Patients With Unresectable Stage III NSCLC Treated With Durvalumab After Chemoradiotherapy: PACIFIC-KR | Oh, Hyung-Joo | Oh, HJ | 2 | Chonnam Natl Univ, Med Sch, Dept Internal Med, 322 Seoyang Ro, Hwasun 58128, Jeonnam, South Korea | droij@jnu.ac.kr; | |||||
| Korean Real-World Data on Patients With Unresectable Stage III NSCLC Treated With Durvalumab After Chemoradiotherapy: PACIFIC-KR | Oh, Hyung-Joo | Oh, HJ | 2 | Hwasun Hosp, 322 Seoyang Ro, Hwasun 58128, Jeonnam, South Korea | droij@jnu.ac.kr; | |||||
| Korean Real-World Data on Patients With Unresectable Stage III NSCLC Treated With Durvalumab After Chemoradiotherapy: PACIFIC-KR | Kim, Young-Chul | Kim, YC | 3 | Chonnam Natl Univ, Med Sch, Dept Internal Med, 322 Seoyang Ro, Hwasun 58128, Jeonnam, South Korea | droij@jnu.ac.kr; | |||||
| Korean Real-World Data on Patients With Unresectable Stage III NSCLC Treated With Durvalumab After Chemoradiotherapy: PACIFIC-KR | Kim, Young-Chul | Kim, YC | 3 | Hwasun Hosp, 322 Seoyang Ro, Hwasun 58128, Jeonnam, South Korea | droij@jnu.ac.kr; | |||||
| Korean Real-World Data on Patients With Unresectable Stage III NSCLC Treated With Durvalumab After Chemoradiotherapy: PACIFIC-KR | Kim, Yong-Hyub | Kim, YH | 4 | Hwasun Hosp, 322 Seoyang Ro, Hwasun 58128, Jeonnam, South Korea | AAK-1840-2021 | Kim, Yong-Joo | droij@jnu.ac.kr; | |||
| Korean Real-World Data on Patients With Unresectable Stage III NSCLC Treated With Durvalumab After Chemoradiotherapy: PACIFIC-KR | Kim, Yong-Hyub | Kim, YH | 4 | Chonnam Natl Univ, Med Sch, Dept Radiat Oncol, Hwasun, Jeonnam, South Korea | AAK-1840-2021 | Kim, Yong-Joo | droij@jnu.ac.kr; | |||
| Korean Real-World Data on Patients With Unresectable Stage III NSCLC Treated With Durvalumab After Chemoradiotherapy: PACIFIC-KR | Ahn, Sung-Ja | Ahn, SJ | 5 | Hwasun Hosp, 322 Seoyang Ro, Hwasun 58128, Jeonnam, South Korea | droij@jnu.ac.kr; | |||||
| Korean Real-World Data on Patients With Unresectable Stage III NSCLC Treated With Durvalumab After Chemoradiotherapy: PACIFIC-KR | Ahn, Sung-Ja | Ahn, SJ | 5 | Chonnam Natl Univ, Med Sch, Dept Radiat Oncol, Hwasun, Jeonnam, South Korea | droij@jnu.ac.kr; | |||||
| Korean Real-World Data on Patients With Unresectable Stage III NSCLC Treated With Durvalumab After Chemoradiotherapy: PACIFIC-KR | Jeong, Won Gi | Jeong, WG | 6 | Hwasun Hosp, 322 Seoyang Ro, Hwasun 58128, Jeonnam, South Korea | droij@jnu.ac.kr; | |||||
| Korean Real-World Data on Patients With Unresectable Stage III NSCLC Treated With Durvalumab After Chemoradiotherapy: PACIFIC-KR | Jeong, Won Gi | Jeong, WG | 6 | Chonnam Natl Univ, Med Sch, Dept Radiol, Hwasun, Jeonnam, South Korea | droij@jnu.ac.kr; |
페이지 이동: